Heterogeneous survival outcomes in molecularly defined acute myeloid leukemia with myelodysplasia-related changes

Blood Neoplasia 2026 Open access

Read full text
Authors: Nicholas L.J. Chornenki, Afraa Mustafa Sulieman Fadul, Analiza Supan, Yasser Abou Mourad, Hannah Marie Cherniawsky, Shanee Chung, Donna Forrest, Deepesh Pravinkumar Lad, Aly Karsan, Florian Kuchenbauer, Eric McGinnis, Stephen H. Nantel
+9 more Sujaatha Narayanan, Thomas J. Nevill, Judith Anula Rodrigo, Claudie Roy, Kevin Song, Cynthia L. Toze, Jennifer White, David Sanford, Ryan J. Stubbins
DOI: 10.1016/j.bneo.2026.100198
Cited by: 0
References: 19

Abstract

< .001). These findings highlight the heterogeneity within the MRC-2022 group, particularly with mutation type and transplant status. Further refinement of AML-MRC risk stratification is needed.

Fields of Study & Subjects

Acute Myeloid Leukemia Research Retinoids in leukemia and cellular processes Chronic Myeloid Leukemia Treatments

Publication details

Journal / source
Blood Neoplasia
Volume
3
Issue
2
Pages
100198–100198
Publication date
14 January 2026
Language
EN